Q-Trial in Patients With Hepatitis C

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Chronic Hepatitis C
Interventions
DIETARY_SUPPLEMENT

Quercetin

Bioflavonoid

Trial Locations (1)

90095

UCLA Jonsson Comprehensive Cancer Center. Factor Building, Los Angeles

All Listed Sponsors
collaborator

American Association for Cancer Research

OTHER

collaborator

Tower Cancer Research Foundation

UNKNOWN

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of California, Los Angeles

OTHER

NCT01438320 - Q-Trial in Patients With Hepatitis C | Biotech Hunter | Biotech Hunter